TRAP5 Inhibition Targeting Scar‐Associated Macrophages Ameliorates Acute Kidney Injury to Chronic Kidney Disease Transition
Advanced Science · 2026
DOI: 10.1002/advs.202519855 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Chenxi Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicin…. Hauptthemen laut MEDLINE: Macrophages, Renal Insufficiency, Chronic, Acute Kidney Injury, Tartrate-Resistant Acid Phosphatase. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Innovation Action Plan of Shanghai Science and Technology Commission, Shanghai Sailing Program, Shanghai Rising-Star Project.
Abstract (Originalsprache)
The transition from acute kidney injury (AKI) to chronic kidney disease (CKD) lacks effective therapies. Using a murine aristolochic acid I model (AAI), followed by a 2 week remodeling phase, we mapped macrophage states across the AKI to CKD transition. Single‐cell RNA sequencing of kidneys from control, acute, and remodeling stages profiled 39 345 cells spanning 18 clusters. Macrophage subclustering and trajectories revealed emergence of scar‐associated macrophages (SMs) marked by high Acp5 (encoding tartrate‐resistant acid phosphatase 5 (TRAP5)) and enriched during the remodeling phase. Cell–cell communication highlighted a dominant Spp1–Cd44 axis driving SM activation. Immunofluorescence confirmed TRAP5 + CD68 + macrophage accumulation in multiple murine CKD and human CKD biopsies. Functionally, pharmacological TRAP5 inhibition conferred robust protection against AKI–CKD transition. TRAP5 blockade initiated in the AKI phase markedly attenuated fibrosis, inflammation, and renal dysfunction in both AAI and ischemia‐reperfusion injury (IRI) models; while preinhibition similarly mitigated unilateral ureteral obstruction (UUO)‐induced fibrosis. In bone marrow‐derived macrophages (BMDMs), TRAP5 blockade abrogated osteopontin (Spp1)‐driven metabolic and profibrotic reprogramming. In conclusion, TRAP5 + scar‐associated macrophages are disease‐promoting effectors of maladaptive remodeling in AKI–CKD transition. Targeting TRAP5 not only suppresses profibrotic macrophage activation but also protects renal structure and function across multiple models, establishing TRAP5 inhibition as a promising therapeutic strategy to halt CKD progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Nephrology, Ruijin Hospital Luwan Branch, Shanghai Jiaotong University School of Medicine, Shanghai, China.
- Department of Nephrology, Shanghai Fourth People's Hospital, Tongji University, Shanghai, China.
- Department of Nephrology, Ningbo Yinzhou No.2 Hospital, Ningbo, China.
- Department of Nephrology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Intensive Care Unit, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
ORCID-Profile: Xiangchen Gu
Förderung
- National Natural Science Foundation of China
- Science and Technology Innovation Action Plan of Shanghai Science and Technology Commission
- Shanghai Sailing Program, Shanghai Rising-Star Project
- Youth Fund of National Natural Science Foundation of China
- Research Startup Funding of Shanghai Fourth People's Hospital Affiliated to Tongji University
Zitieren
APA
Wang, C., Gu, Y., Du, W., Xie, L., Quan, J., Zhao, Y., Cheng, Y., Wei, Z., Sha, Y., Wang, Y., Xu, D., Gao, X., Chen, M., & Gu, X. (2026). TRAP5 Inhibition Targeting Scar‐Associated Macrophages Ameliorates Acute Kidney Injury to Chronic Kidney Disease Transition. Advanced Science. https://doi.org/10.1002/advs.202519855
Vancouver
Wang C, Gu Y, Du W, Xie L, Quan J, Zhao Y, et al. TRAP5 Inhibition Targeting Scar‐Associated Macrophages Ameliorates Acute Kidney Injury to Chronic Kidney Disease Transition. Advanced Science. 2026. doi:10.1002/advs.202519855
BibTeX
@article{Wang2026,
author = {Wang, Chenxi and Gu, Yaodong and Du, Wen and Xie, Lin and Quan, Jinwei and Zhao, Yu and Cheng, Ye and Wei, Zhaonan and Sha, Yuanyuan and Wang, Yi and Xu, Dechao and Gao, Xiang and Chen, Min and Gu, Xiangchen},
title = {TRAP5 Inhibition Targeting Scar‐Associated Macrophages Ameliorates Acute Kidney Injury to Chronic Kidney Disease Transition},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202519855}
}
EUVIMED